Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions.

Yu, Yi-Xuan; Wang, Shuo; Liu, Zhe-Ning; Zhang, Xu; Hu, Zi-Xin; Dong, Hui-Jing; Lu, Xing-Yu; Zheng, Jia-Bin; Cui, Hui-Juan

Yu, Yi-Xuan; Wang, Shuo; Liu, Zhe-Ning; Zhang, Xu; Hu, Zi-Xin; Dong, Hui-Jing; Lu, Xing-Yu; Zheng, Jia-Bin; Cui, Hui-Juan.

Affiliation

Yu YX; Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China.
Wang S; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, No.2 Yinghua East Road, Chaoyang District, Beijing, 100029, China.
Liu ZN; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, No.2 Yinghua East Road, Chaoyang District, Beijing, 100029, China.
Zhang X; Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China.
Hu ZX; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, No.2 Yinghua East Road, Chaoyang District, Beijing, 100029, China.
Dong HJ; Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China.
Lu XY; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, No.2 Yinghua East Road, Chaoyang District, Beijing, 100029, China.
Zheng JB; Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China.
Cui HJ; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, No.2 Yinghua East Road, Chaoyang District, Beijing, 100029, China.

Chin Med ; 18(1): 59, 2023 May 20.

Article de En | MEDLINE | ID: mdl-37210537

Mots clés

Immune checkpoint inhibitor; Immunotherapy; Traditional Chinese Medicine; Tumor microenvironment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Chin Med Année: 2023 Type de document: Article Pays d'affiliation: Chine